Eileen Francis
Reporter
Washington DC, USA
23+ years of experience
Eileen started her journalism career as a reporter for Rose Sheet covering news relating to personal care R&D, new products, M&A and marketing, before assuming the role of managing editor. She later joined the Tan Sheet, broadening her expertise to OTC drugs and dietary supplements. Both Rose Sheet and Tan Sheet now are part of HBW Insight.
Early in her career, she served as a writer for a lobbying firm and as a blogger covering patent law news for an international law firm. Outside of Pharma Intelligence, her freelance work includes articles on business, art and travel. When not sitting behind her desk, Eileen is usually found running on a trail or treadmill.
HBW Insight
By Eileen Francis 26 May 2021
Senate bill provision allowing FDA to develop unique labeling and packaging for cannabinoid supplements and foods is unnecessary, as the products should following existing labeling regulations, says CRN chief Steve Mister.
HBW Insight
By Eileen Francis 15 Jul 2020
Assertions that no convincing evidence supports that probiotics available in the US treat symptoms of diarrhea, irritable bowel syndrome or allergies look at the category as a whole and not individual strains shown to help with specific conditions, say consumer health industry groups.
Topic Coronavirus Dietary Supplements Research & Development
HBW Insight
By Eileen Francis 05 Jun 2020
Researchers say “no strong” evidence shows high vitamin D intake is beneficial to preventing or treating COVID-19, but adequate levels are needed to support immunity. Other researchers say countries should increase recommended vitamin D levels with “very suggestive” evidence supporting its effect against COVID-19 severity.
Topic Coronavirus
HBW Insight
By Eileen Francis 13 Nov 2019
In latest study casting doubt on the nutrients' effect on chronic illness, researchers find vitamin D and fish oil ineffective in staving off type 2 diabetics' kidney failure. Editorial also published in JAMA says further research is needed to analyze the nutrients’ possible benefits to diabetics with chronic kidney disease.
Topic Clinical Trials
HBW Insight
By Eileen Francis 23 Jan 2019
Amazon’s Solimo supplement and Basic Care OTC lines unlikely to expand much, says Jefferies analyst Brian Tanquilut. Still, brands are well positioned against retail private label competitors, as most products are priced lower than similar products by Walgreens and CVS.
Topic Drug Review
HBW Insight
26 Jul 2022
HBW Insight
15 Jul 2022
HBW Insight
13 Jul 2022
HBW Insight
05 Jul 2022
HBW Insight
18 Jun 2022
HBW Insight
02 Jun 2022
HBW Insight
27 May 2022
HBW Insight
25 May 2022
HBW Insight
22 May 2022
HBW Insight
17 May 2022
HBW Insight
12 May 2022
HBW Insight
09 May 2022
HBW Insight
03 May 2022
HBW Insight
28 Apr 2022
HBW Insight
25 Apr 2022